EASL Studio Podcast: Alcohol, cardiometabolic risks factors, and steatotic liver disease – From stigma to breakthrough therapies

This EASL Studio episode explores how alcohol worsens liver disease in patients with cardiometabolic risks, the stigma affecting diagnosis and care, and the latest therapeutic advances.Key topics of discussion include:Interaction between alcohol and cardiometabolic risksStigma and its impact on patient careIdentifying at-risk patients with clinical markersEmerging therapies and research opportunitiesFacultyAleksander Krag (Moderator)Fredrik Åberg (Faculty)Maru Rinella (Faculty)Maja Thiele (Faculty)This EASL Studio is supported by Boehringer Ingelheim. EASL has received no input from Boehringer Ingelheim with regards to the content of this programme.Related episodesEASL Studio S5E9: Alcohol and the new nomenclature – A game-changer?EASL Studio S4E8: The central role of alcohol and food policies on liver healthEASL Studio S4E3: A 360 approach to beat alcohol-related liver diseaseEASL Studio S3E5: JHEP Live: Stigma and alcoholAll EASL Studio Podcasts are available on EASL Campus.